These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15125930)

  • 1. Synthesis of new fluoroquinolones and evaluation of their in vitro activity on Toxoplasma gondii and Plasmodium spp.
    Anquetin G; Rouquayrol M; Mahmoudi N; Santillana-Hayat M; Gozalbes R; Greiner J; Farhati K; Derouin F; Guedj R; Vierling P
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2773-6. PubMed ID: 15125930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and activity against Toxoplasma gondii, Plasmodium spp., and Mycobacterium tuberculosis of new 6-fluoroquinolones.
    Anquetin G; Greiner J; Mahmoudi N; Santillana-Hayat M; Gozalbes R; Farhati K; Derouin F; Aubry A; Cambau E; Vierling P
    Eur J Med Chem; 2006 Dec; 41(12):1478-93. PubMed ID: 17000032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of new 7-chloroquinolinyl thioureas and their biological investigation as potential antimalarial and anticancer agents.
    Mahajan A; Yeh S; Nell M; van Rensburg CE; Chibale K
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5683-5. PubMed ID: 17768052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro activities of ferrocenic aminohydroxynaphthoquinones against Toxoplasma gondii and Plasmodium falciparum.
    Baramee A; Coppin A; Mortuaire M; Pelinski L; Tomavo S; Brocard J
    Bioorg Med Chem; 2006 Mar; 14(5):1294-302. PubMed ID: 16242338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.
    Diaz CA; Allocco J; Powles MA; Yeung L; Donald RG; Anderson JW; Liberator PA
    Mol Biochem Parasitol; 2006 Mar; 146(1):78-88. PubMed ID: 16325279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity studies of some berberine analogs as inhibitors of Toxoplasma gondii.
    Krivogorsky B; Pernat JA; Douglas KA; Czerniecki NJ; Grundt P
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2980-2. PubMed ID: 22425568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salicylanilide inhibitors of Toxoplasma gondii.
    Fomovska A; Wood RD; Mui E; Dubey JP; Ferreira LR; Hickman MR; Lee PJ; Leed SE; Auschwitz JM; Welsh WJ; Sommerville C; Woods S; Roberts C; McLeod R
    J Med Chem; 2012 Oct; 55(19):8375-91. PubMed ID: 22970937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening.
    Mahmoudi N; de Julián-Ortiz JV; Ciceron L; Gálvez J; Mazier D; Danis M; Derouin F; García-Domenech R
    J Antimicrob Chemother; 2006 Mar; 57(3):489-97. PubMed ID: 16415127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro antiplasmodial activities of fluoroquinolone analogs.
    Dixit SK; Mishra N; Sharma M; Singh S; Agarwal A; Awasthi SK; Bhasin VK
    Eur J Med Chem; 2012 May; 51():52-9. PubMed ID: 22424611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations.
    Ling Y; Sahota G; Odeh S; Chan JM; Araujo FG; Moreno SN; Oldfield E
    J Med Chem; 2005 May; 48(9):3130-40. PubMed ID: 15857119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiparasitic evaluation of bis-2,5-[4-guanidinophenyl]thiophenes.
    Gonzalez JL; Stephens CE; Wenzler T; Brun R; Tanious FA; Wilson WD; Barszcz T; Werbovetz KA; Boykin DW
    Eur J Med Chem; 2007 Apr; 42(4):552-7. PubMed ID: 17178177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of multicomponent reactions to antimalarial drug discovery. Part 3: discovery of aminoxazole 4-aminoquinolines with potent antiplasmodial activity in vitro.
    Musonda CC; Little S; Yardley V; Chibale K
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4733-6. PubMed ID: 17644333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antimalarial and fluoroquinolone combinations against Plasmodium falciparum in vitro.
    Soares RP; Krettli AU; de Souza MV; Vasconcelos TR; Boechat N
    Int J Antimicrob Agents; 2006 Sep; 28(3):271-2. PubMed ID: 16904872
    [No Abstract]   [Full Text] [Related]  

  • 15. Total synthesis of the cyanobacterial metabolite nostodione A: discovery of its antiparasitic activity against Toxoplasma gondii.
    McNulty J; Keskar K; Bordón C; Yolken R; Jones-Brando L
    Chem Commun (Camb); 2014 Aug; 50(64):8904-7. PubMed ID: 24970332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Original quinazoline derivatives displaying antiplasmodial properties.
    Kabri Y; Azas N; Dumètre A; Hutter S; Laget M; Verhaeghe P; Gellis A; Vanelle P
    Eur J Med Chem; 2010 Feb; 45(2):616-22. PubMed ID: 19926173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxoplasma gondii: a simple high-throughput assay for drug screening in vitro.
    Jin C; Kaewintajuk K; Jiang J; Jeong W; Kamata M; Kim HS; Wataya Y; Park H
    Exp Parasitol; 2009 Feb; 121(2):132-6. PubMed ID: 18977350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 4-Amino 2-Anilinoquinazolines against
    Gilson PR; Nguyen W; Poole WA; Teixeira JE; Thompson JK; Guo K; Stewart RJ; Ashton TD; White KL; Sanz LM; Gamo FJ; Charman SA; Wittlin S; Duffy J; Tonkin CJ; Tham WH; Crabb BS; Cooke BM; Huston CD; Cowman AF; Sleebs BE
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro antiplasmodial evaluation of 4-anilino-2-trichloromethylquinazolines.
    Verhaeghe P; Azas N; Hutter S; Castera-Ducros C; Laget M; Dumètre A; Gasquet M; Reboul JP; Rault S; Rathelot P; Vanelle P
    Bioorg Med Chem; 2009 Jul; 17(13):4313-22. PubMed ID: 19482476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-toxoplasma activities of 24 quinolones and fluoroquinolones in vitro: prediction of activity by molecular topology and virtual computational techniques.
    Gozalbes R; Brun-Pascaud M; Garcia-Domenech R; Galvez J; Girard PM; Doucet JP; Derouin F
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2771-6. PubMed ID: 10991859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.